We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.64%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$26.1B
AUM Growth
+$1.03B
(+4.1%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
13.61%
Holding
1,470
New
112
Increased
493
Reduced
531
Closed
130
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$94.2M |
| 2 |
Medtronic
MDT
|
+$83.5M |
| 3 |
Verizon
VZ
|
+$54.1M |
| 4 |
Adobe
ADBE
|
+$54.1M |
| 5 |
Amazon
AMZN
|
+$50.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$81.3M |
| 2 |
Sensata Technologies
ST
|
+$78M |
| 3 |
PG&E
PCG
|
+$52M |
| 4 |
Amgen
AMGN
|
+$43.5M |
| 5 |
Lowe's Companies
LOW
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.67% |
| 2 | Healthcare | 15.83% |
| 3 | Consumer Discretionary | 11.21% |
| 4 | Financials | 11.2% |
| 5 | Industrials | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCPH
726
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $3.23M | 0.01% |
+82,196
| New | +$2.42M |
|
727
First Horizon
FHN
$11.3B
| $3.23M | 0.01% |
181,000
+41,600
| +30% | +$783K |
|
728
JD.com
JD
$36.2B
| $3.2M | 0.01% |
82,132
-515,069
| -86% | -$19.9M |
|
729
Stoneridge
SRI
$202M
| $3.17M | 0.01% |
90,244
+2,100
| +2% | +$63.8K |
|
730
Vera Bradley
VRA
$116M
| $3.17M | 0.01% |
225,799
-50,160
| -18% | -$603K |
|
|
UNVR
731
DELISTED
Univar Solutions Inc.
UNVR
| $3.17M | 0.01% |
120,629
| – | – |
|
732
Alexandria Real Estate Equities
ARE
$9.1B
| $3.15M | 0.01% |
24,996
+645
| +3% | +$80.6K |
|
|
EIGI
733
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $3.11M | 0.01% |
+312,800
| New | +$2.68M |
|
734
Rexford Industrial Realty
REXR
$8.63B
| $3.11M | 0.01% |
98,947
+4,837
| +5% | +$148K |
|
735
ACI Worldwide
ACIW
$5.19B
| $3.1M | 0.01% |
125,660
+80,706
| +180% | +$1.97M |
|
736
LendingTree
TREE
$370M
| $3.1M | 0.01% |
14,500
-31,600
| -69% | -$8.76M |
|
737
Mohawk Industries
MHK
$8.65B
| $3.06M | 0.01% |
14,262
-12,144
| -46% | -$2.66M |
|
|
CAVM
738
DELISTED
Cavium, Inc.
CAVM
| $3.03M | 0.01% |
35,000
| – | – |
|
739
Nucor
NUE
$58.7B
| $3M | 0.01% |
48,011
+139
| +0.3% | +$8.87K |
|
740
Trip.com Group
TCOM
$25.5B
| $2.99M | 0.01% |
62,828
-7,672
| -11% | -$347K |
|
741
Restaurant Brands International
QSR
$26.2B
| $2.99M | 0.01% |
49,615
-33,964
| -41% | -$1.95M |
|
742
SLR Investment Corp
SLRC
$655M
| $2.99M | 0.01% |
146,200
| – | – |
|
743
OSI Systems
OSIS
$3.2B
| $2.98M | 0.01% |
38,600
-5,000
| -11% | -$349K |
|
744
iShares MSCI Australia ETF
EWA
$1.26B
| $2.98M | 0.01% |
131,915
+42,600
| +48% | +$959K |
|
|
FITB
745
Fifth Third Bancorp
FITB
$47.3B
| $2.98M | 0.01% |
103,860
-649
| -0.6% | -$20.6K |
|
746
AGCO
AGCO
$8.34B
| $2.96M | 0.01% |
48,800
-85,000
| -64% | -$5.43M |
|
747
Motorola Solutions
MSI
$76.2B
| $2.95M | 0.01% |
25,386
-114
| -0.4% | -$12.6K |
|
|
BOLD
748
DELISTED
Audentes Therapeutics, Inc
BOLD
| $2.95M | 0.01% |
77,309
+984
| +1% | +$36.4K |
|
749
International Flavors & Fragrances
IFF
$21.4B
| $2.95M | 0.01% |
23,823
-17,151
| -42% | -$2.24M |
|
750
GoDaddy
GDDY
$12.5B
| $2.95M | 0.01% |
41,781
+24,591
| +143% | +$1.67M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2018 Portfolio in Review
As of Q2 2018, Axa held 1,470 positions worth $26.1B, up 4.1% from $25.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa's Q2 2018 filing shows 112 new, 493 increased, 531 reduced and 130 closed positions. Its largest new stake was Foot Locker: 289,100 shares worth $15.2M. The largest sale was AbbVie, an estimated $81.3M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Axa's largest Q2 2018 buy was Foot Locker: 289,100 shares worth $15.2M.
- Axa added most to TE Connectivity in Q2 2018, an estimated $94.2M increase.
- Axa's biggest Q2 2018 reduction was AbbVie, cutting an estimated $81.3M.
- Axa fully exited PG&E in Q2 2018, selling an estimated $52M.
- Axa's ten largest holdings make up 14% of its $26.1B portfolio in Q2 2018.
- Axa opened 112 new positions and closed 130 in Q2 2018.
- Axa's portfolio value rose 4.1% quarter-over-quarter to $26.1B.
Based on Axa's 13F filing for Q2 2018, filed 13 Aug 2018.